This document discusses fertility preservation options for young women diagnosed with gynecologic cancers. It covers cervical, endometrial, and ovarian cancers. For early-stage cervical cancer, conization or radical trachelectomy can allow fertility preservation. For early-stage endometrial cancer, hormonal treatment with progesterone may induce remission and allow attempted pregnancy. For early-stage ovarian cancers including borderline tumors and germ cell tumors, fertility-sparing surgery such as unilateral salpingo-oophorectomy may be an option. Patient selection is crucial to balance oncologic and fertility outcomes.
Advance in diagnosis & treatment of cancers has led to high cure rate & longer survival.
Nearly 1 in 12 cases detected before 40 years age.
Survivors have to face infertility or early menopause.
In gynecologic cancers, fertility preservation strategies include fertility-sparing surgical approaches and assisted reproductive technologies (ART). Fertility preservation can be considered in women with early stage I epithelial ovarian cancer and most borderline tumors, stages I–III
Increase incidence of cancer during the reproductive age. Survival and cure rates of cancer are improving. Resulting in Increasing demand for fertility preserving interventions.
Fertility preservation in Cancer patientsArunSharma10
The need for fertility preservation
Chemotherapeutic drugs according to gonadotoxicity level
Fertility preservation: subject of continuous review by experts
Non-oncological conditions requiring fertility preservation
Delayed childbearing
AVAILABLE PROCEDURES FOR FP
Embryo and oocyte cryopreservation
Advance in diagnosis & treatment of cancers has led to high cure rate & longer survival.
Nearly 1 in 12 cases detected before 40 years age.
Survivors have to face infertility or early menopause.
In gynecologic cancers, fertility preservation strategies include fertility-sparing surgical approaches and assisted reproductive technologies (ART). Fertility preservation can be considered in women with early stage I epithelial ovarian cancer and most borderline tumors, stages I–III
Increase incidence of cancer during the reproductive age. Survival and cure rates of cancer are improving. Resulting in Increasing demand for fertility preserving interventions.
Fertility preservation in Cancer patientsArunSharma10
The need for fertility preservation
Chemotherapeutic drugs according to gonadotoxicity level
Fertility preservation: subject of continuous review by experts
Non-oncological conditions requiring fertility preservation
Delayed childbearing
AVAILABLE PROCEDURES FOR FP
Embryo and oocyte cryopreservation
Role of Stem Cells in Obstetrics and Gynecology PracticeAsha Jain
Role of Stem Cells in Obstetrics and Gynecology Practice
Talk delivered at 4th Biennial International ISCSGCON 2021
on Febuary 13,2021 by Dr. Asha Jain
Invited Lecture delivered by Dr Sujoy Dasgupta in the Annual Conference of ISAR (Indian Society of Assisted Reproduction) held at Kolkata in November, 2019
Selective progesterone receptor modulators (SPRMs)
Stimulates growth :
Up regulating epidermal growth factor (EGF)
Down regulating tumour necrosis factor-alpha expression
Inhibits growth :
Downregulating insulin-like growth factor-1 (IGF-1) expression
NO EFFECT ON ESTRADIOL LEVELS
Mifepristone : 5 or 10 mg per day for 1 year
Ulipristal acetate: 5-10mg/day for 13 weeks
Pro apoptotic and anti-proliferative effects on fibroid cells
this presentation highlights the principles of uterine and ovarian transplantation. It explores the past and examines the current status for uterine and ovarian factor infertility.
interest in stem cells is raising in different field of medicine. The question is : is it successful in Gynecology or it is still too early to say that. The present talk may help to explore this .
Role of Stem Cells in Obstetrics and Gynecology PracticeAsha Jain
Role of Stem Cells in Obstetrics and Gynecology Practice
Talk delivered at 4th Biennial International ISCSGCON 2021
on Febuary 13,2021 by Dr. Asha Jain
Invited Lecture delivered by Dr Sujoy Dasgupta in the Annual Conference of ISAR (Indian Society of Assisted Reproduction) held at Kolkata in November, 2019
Selective progesterone receptor modulators (SPRMs)
Stimulates growth :
Up regulating epidermal growth factor (EGF)
Down regulating tumour necrosis factor-alpha expression
Inhibits growth :
Downregulating insulin-like growth factor-1 (IGF-1) expression
NO EFFECT ON ESTRADIOL LEVELS
Mifepristone : 5 or 10 mg per day for 1 year
Ulipristal acetate: 5-10mg/day for 13 weeks
Pro apoptotic and anti-proliferative effects on fibroid cells
this presentation highlights the principles of uterine and ovarian transplantation. It explores the past and examines the current status for uterine and ovarian factor infertility.
interest in stem cells is raising in different field of medicine. The question is : is it successful in Gynecology or it is still too early to say that. The present talk may help to explore this .
June 1, 2016◆Volume 93, Number 11www.aafp.org/afpAmerican Family Physician 937Ovarian cancer is the most lethal gynecologic cancer. Less than one-half of patients survive for more than five years after diagnosis. Ovarian cancer affects women of all ages but is most commonly diagnosed after menopause. More than 75% of affected women are diagnosed at an advanced stage because early-stage disease is usually asymptomatic and symptoms of late-stage disease are nonspecific. The strongest risk factors are advancing age and family history of ovarian and breast cancer.
Current knowledge and state of the art about management of abnormal cervical Cancer screening tests and cancer precursors for health providers in low-income settings is presented.
From Queens Library's expert-led panel, Cancer Awareness: What You Need to Know, featuring professionals from New York Hospital Queens, North Shore LIJ, the American Cancer Society, and the Leukemia and Lymphoma Society
BRCA – Importance in Hereditary Breast & Ovarian CancerLifecare Centre
BRCA – Importance in Hereditary
Breast & Ovarian Cancer
DGF & WOW India
presentation was made by
Dr Sharda Jain
based on presentation made by
Dr Sunil Tadepalli
Similar to Fertility Preservation for Gynecologic Cancer Patients (20)
Experiential Learning through the lens of Communities of Practice (CoP) theoryJibran Mohsin
Individual Presentation on "Experiential Learning through the lens of Communities of Practice (CoP) theory"
Advanced Level Course on Teaching and Learning 1
Master of Health Professions Education
Department for Educational Development
The Aga Khan University
Tuesday, February 07, 2023
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomized, open-label, phase 3 trial
CURRICULUM ON RESIDENCY PROGRAM FOR FCPS MOLECULAR PATHOLOGYJibran Mohsin
CURRICULUM ON RESIDENCY PROGRAM FOR FCPS MOLECULAR PATHOLOGY (Advanced Level Course on Curriculum Development in Health Professions Education, Department for Educational Development, The Aga Khan University)
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
NVBDCP.pptx Nation vector borne disease control program
Fertility Preservation for Gynecologic Cancer Patients
1. Shaukat Khanum Memorial Cancer Hospital and Research Centre
Iqra Yasin
Fertility Preservation for
Gynecologic Cancer Patients
Fellow Gynecologic Oncology
SKMCH & RC, Lahore
2. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Outline
Introduction
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
Conclusion
References
3. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Introduction
Overall cancer risk in females <39 years (1:39)
In young women
Cervical cancer 2%
Endometrial cancer 5%
Ovarian cancer 12 %
5 year survival
46% in ovarian cancer to 80% in endometrial cancer
Over 90% in borderline ovarian tumor
4. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Introduction
Gynecologic Malignancies – Often diagnosed in postmenopausal
age
Rise in a trend seen in premenopausal age
Traditional management = TAH + BSO (permanent sterility)
Fertility preservation: important at young age
Patient selection: Crucial
5. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Incidence: 1.5 – 14.9 per 100,000 (20 – 49 years)
45 % of early-stage IB surgically removed:
< 40 years of age.
Standard management:
Radical hysterectomy + systematic pelvic LND
Ovarian preservation and upper transposition:
Pelvic RT in young age
6. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
1. Excisional conization of the cervix
7. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Indications of cervical conization (microscopic disease)
Stage DOI Horizontal
Spread
Cervical
Conization
Risk of LN
metastases
Systemic
Pelvic LND
IA1 < 3 mm < 7 mm + 0.5 – 1.5 % -
IA2 < 5 mm < 7 mm + 5 – 8 % +
8. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
2. Radical Trachelectomy/cervicectomy (Greek: trachelos – neck)
Approaches
a. Vaginal
b. Abdominal
a. Pediatric, nullipara
b. distorted anatomy
c. Cervical stump tumor
d. Exophytic cervical tumor
9. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
2. Radical Trachelectomy (Patient Selection)
1. Strong desire to preserve fertility
2. Histopathological diagnosis with proven diagnosis of cervical cancer by
expertise
3. SCC / AdenoCA / Adenosquamous CA
4. Stage IA1 with LVSI , IA2 and IB1
5. Tumor size < 2 cm
6. No evidence of pelvic LN or distant metastases
10. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
2. Radical Trachelectomy (Preoperative assessment)
1. Colposcopy
2. Histopathology review by second expertise (type, depth, LVSI)
3. MRI
11. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
2. Radical Trachelectomy (steps)
a) Systemic Pelvic Lymphadenectomy
b) Excision of cervix + Para cervix + 1-2 cm of vagina
c) Upper cervical or isthmic cerclage
d) Reconstruction of uterine corpus to upper vagina
12. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
13. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
Radical Trachelectomy (Follow-up)
Cytologic (vaginal +isthmic smear) and colposcopic
evaluation
0-2 years ( every 3-4 months) , > 2 years (every 6 months)
Yearly MRI
14. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
Radical Trachelectomy
Obstetrical Outcomes
2nd trimester miscarriage
Preterm birth
Oncologic Outcomes
5 years survival 98.4 %
Relapse rate 4.5 %
15. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
Radical vaginal Trachelectomy vs radical hysterectomy
Same or less morbidity
No significant difference in intra and post operative
complications
No difference in 5-year OS, RFS, PFS
16. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer
Fertility sparing procedures
Radical Trachelectomy (Conclusion)
Radical hysterectomy, the “gold standard” traditional treatment
for patients with early stage cervical cancer has been recently
replaced by radical trachelectomy – vaginal or abdominal route
– for young women with strong desire for fertility preservation.
17. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Cervical Cancer (NCCN / Summary)
18. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
Most common gynecologic malignancy
Median age of diagnosis: 61 years
Incidence: 1.2 – 24 per 100,000 (25 – 49 years)
Standard management: TAH +BSO + PLND +/- Para-aortic
LND
19. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
Fertility preserving options
Hormonal treatment
Patient selection
Well-differentiated endometrioid AdenoCA confirm by expert
pathology review
Disease limited to endometrium without myometrium
Absence of any suspicious or metastatic disease
Absence of LVSI
No contraindication to medical therapy
Strong desire to preserve fertility (understanding of fertility-
preserving – not standard of care)
20. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
Fertility preserving options
Hormonal treatment
Oral Progesterone (Megestrol acetate,
medroxypogesterone acetate)
LNG – IUD
MOA: inhibit estrogen receptor function and endometrial
cell mitosis, promote apoptosis
Duration: at least 6 months
Meta-analysis: improved outcomes (IUD LNG > oral
progesterone)
21. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
Fertility preserving options
Hormonal treatment
Follow up
Every 3-6 months (endometrial sampling)
Oncologic Outcomes
Persistent disease (25 %): Hysterectomy
Partial response (25%): Medication for additional 3 – 6
months
Complete response (50 %) : Encourage fertility treatment
22. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
Fertility preserving options
Hormonal treatment
Recurrence rate: 40 % (15 months)
Encourage to have pregnancy using ART
Obstetrical Outcomes:
Successful pregnancy significant reduced risk of
recurrence
IVF doesn’t increase the risk of recurrence
5 DFS (ovulation induction = spontaneous conception)
23. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
24. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Endometrial Cancer
(NCCN / Summary)
25. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Leading cause of death from gynecologic malignancies in western countries
Majority in postmenopausal age
Incidence
20 – 49 year = 1.6 -16 per 100,000
< 20 years = 0.7 – 1.4 per 100,000
Standard management:
Exploratory laparotomy + FS of ovarian tumor
If invasive – TAH + BSO + debulking omentectomy + PLND + Para-
aortic LND, multiple peritoneal washings and biopsies
26. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Fertility preserving options
Comprehensive surgical staging –a mainstay of the
conservative surgical approach
Removal of ipsilateral adnexa
Preservation of uterus and contralateral adnexa
Omentectomy and multiple peritoneal biopsies
Evaluation of retroperitoneal space through pelvic and para-
aortic lymphadenectomy
27. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Fertility preserving options
Indications:
Epithelial ovarian cancer
Stage IA, grade I, Serous/mucinous/endometrioid variety
Not for
clear cell, small cell and anaplastic tumors,
high grade serous/mucinous/endometrioid variety
Hereditary syndrome (BRCA)
Synchronous endometrial cancer
Stage > 1 or grade 3
28. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Borderline / low malignant potential tumors (BOT)
10-15 % EOC (1/3rd of ovarian cancer < 40 years)
Suitable candidate for FSS (excellent prognosis even at an advanced
stage)
Recurrence (0-25 %, not affect survival rate)
Fertility preserving procedures
Cystectomy: Not recommended (40 % relapse rate)
Bilateral BOT: unilateral SO + contralateral cystectomy
Routine biopsy of a contralateral healthy ovary is not
recommended
LND: lymphadenomegaly or peritoneal spread
29. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Borderline / low malignant potential tumors (BOT)
Follow up
Every 6 months (0-3 years), then yearly
Prolong F/U: Late recurrence
Oncologic outcomes
Survival rate: 99 % (stage 1) to 89 % (stage 3)
Recurrence rate: 0 - 25 %
30. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Germ-Cell Tumor (GCT)
3 -5 % of ovarian tumor
Age: < 20 years
Good prognosis (even for extraperitoneal spread),
Good response to chemotherapy (good candidate for FS options)
OS: not affected by FS options
Relapse: Grade II/III, Advanced stages
Adjuvant therapy (BEP):
excellent cure rate 95 % for early stage,
less toxic to ovaries,
endocrine function intact
31. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Ovarian Cancer
Sex-cord Stromal tumors
Rare neoplasms
Common at a young age
Fertility-Preserving Procedure:
Unilateral salpino-oophorectomy + peritoneal surgical staging (safe
alternative to radical surgery)
LND: not favorable according to literature
Further studies are required to evaluate the safety of the conservative
approach and to define obstetrical outcomes
32. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Conclusion
Fertility preservation options for early-stage gynecological cancers indicate
oncological safety.
Enables cancer patients at a young age to complete their family without
compromising the oncological outcome
Patient selection and counseling are crucial.
Further studies are needed to investigate the role of fertility-sparing treatment
in high-grade cancers and obstetrical outcomes in rare gynecologic tumors.
33. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
References
Abu-Rustum NR, Sonoda Y, Black D, Levine DA, Chi DS, Barakar RR. Fertility-sparing radical abdominal trachelectomy for
cervical carcinoma: Technique and review of the literature. Gynecol Oncol 2006;103(3):807-13.
Chiva L, Lapuente F, Gonzalez-Cortijo L, Carball N, Garcia JF, Rojo JF, Gonzalez-Martin A. Sparing fertility in young patients
with endometrial cancer. Gynecol Oncol 2008;111(2 suppl):S101-104.
Cibula D, Slama J, Fiscerova D. Update on abdominal radical trachelectomy. Gynecol Oncol 2008;111(2 Suppl):111-115.
Erkanli S, Ayhan A. Fertility-sparing therapy in young women with endometrial cancer. Int J Gynecol Cancer 2010;20:1170-1177.
Gershenson DM. Contemporary treatment of borderline ovarian tumors. Cancer Invest 1999;17(3):206-10.
Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol 2007;25(20):2938-43.
Gien LT, Covens A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol 2010;117(2):350-357.
Lai CH, Chang TC, Hsueh S et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol
2005;96:784-791.
Larson DM, Johnson KK, Broste SK et al. Comparison of D&C and office endometrial biopsy in predicting final histopathologic
grade in endometrial cancer. Obstet Gynecol 1995;86:38-42.
Leitao MM, Chi DS. Fertility-sparing options for patients with gynaecologic malignancies. Oncologist 2005;10(8):613-22.
Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H. Reproduction beyond cancer: a message of hope for young women.
Gynecol Oncol 2006;103(3):1109-21.
Milliken DA, Shepherd JH. Fertility preserving surgery for carcinoma of the cervix. Curr Opin Oncol 2008;20(5):575- 80.
Muruyaesu N, Schmid P, Dancey G et al. Malignant ovarian germ cell tumors : Identification of noval prognostic markers and
long-term outcome after multimodality treatment. J Clin Oncol 2006;24:4862-4866.
34. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
References
Oark TJ, Voit D, Gupta JK et al. Accuracy of hysterescopy in the diagnosis of endometrial cancer and hyperplasia: A systematic quantitative
review. JAMA 2002;288:1610-1621.
Rob L, Pluta N, Skapa P, Robora H. Advances in fertilitysparing surgery for cervical cancer. Expert Rev Anticancer Ther 2010;10(7):1101-
1114.
Tangjitgamol S, Manusizivithaya S, Hanprassertpong J. Fertility sparing in endometrial cancer. Gynecol Obstet Invest 2009;67:250-268.
Ramirez PT, Pareja R, Rendon GJ, Millan C, Frumovitz M, Schmeler KM. Management of low-risk early-stage cervical cancer: should
conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care? Gynecol Oncol. 2014
132(1):254-9.
Rob L, Pluta M, Skapa P, Robova H. Advances in fertilitysparing surgery for cervical cancer. Expert Rev Anticancer Ther. 2010;10(7):1101-
14.
Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2011;12(2):192-200.
Reade CJ, Eiriksson LR, Covens A. Surgery for early stage cervical cancer: how radical should it be? Gynecol Oncol. 2013;131(1):222-30.
Gien LT, Covens A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol. 2010;117(2):350-7.
Rodolakis A, Biliatis I, Morice P, Reed N, Mangler M, Kesic V, Denschlag D. European Society of Gynaecological Oncology Task Force for
Fertility Preservation: Clinical Recommendations for Fertility-Sparing Management in Young Endometrial Cancer Patients. Int J Gynecol
Cancer. 2015;25(7):1258-65.
Morice P, Denschlag D, Rodolakis A, Reed N, Schneider A, Kesic V, Colombo N; Fertility Task Force of the European Society of
Gynaecologic Oncology. Recommendations of the Fertility Task Force of the European Society of Gynaecologic Oncology about the
conservative management of ovarian malignant tumors. Int J Gynecol Cancer. 2011;21(5):951-63.
Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, Rodolakis A. Clinical recommendation on fertility preservation in
borderline ovarian neoplasm: Ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest. 2010;70(3):160-5.
Thomakos N, Trachana SP, Rodolakis A, Bamias A, Antsaklis A. Less Radical Surgery for Fertility Preservation in Patients with Early-Stage
Invasive Cervical Cancer Contemporary Problematics. Gynecol Obstet 2013;3:165.
35. Click to edit Master title style
Shaukat Khanum Memorial Cancer Hospital and Research Centre
THANK YOU